Literature DB >> 26583951

Multivariate piecewise exponential survival modeling.

Yan Li1, Orestis A Panagiotou2, Amanda Black2, Dandan Liao3, Sholom Wacholder2.   

Abstract

In this article, we develop a piecewise Poisson regression method to analyze survival data from complex sample surveys involving cluster-correlated, differential selection probabilities, and longitudinal responses, to conveniently draw inference on absolute risks in time intervals that are prespecified by investigators. Extensive simulations evaluate the developed methods with extensions to multiple covariates under various complex sample designs, including stratified sampling, sampling with selection probability proportional to a measure of size (PPS), and a multi-stage cluster sampling. We applied our methods to a study of mortality in men diagnosed with prostate cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial to investigate whether a biomarker available from biospecimens collected near time of diagnosis stratifies subsequent risk of death. Poisson regression coefficients and absolute risks of mortality (and the corresponding 95% confidence intervals) for prespecified age intervals by biomarker levels are estimated. We conclude with a brief discussion of the motivation, methods, and findings of the study.
© 2015, The International Biometric Society.

Entities:  

Keywords:  Absolute risks; Complex sampling designs; Marginal prediction; PLCO; Poisson regression; Probability proportional to a measure of size (PPS)

Mesh:

Year:  2015        PMID: 26583951      PMCID: PMC4976062          DOI: 10.1111/biom.12435

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  7 in total

1.  Piecewise exponential survival times and analysis of case-cohort data.

Authors:  Yan Li; Mitchell H Gail; Dale L Preston; Barry I Graubard; Jay H Lubin
Journal:  Stat Med       Date:  2012-03-13       Impact factor: 2.373

2.  Poisson regression analysis of ungrouped data.

Authors:  D Loomis; D B Richardson; L Elliott
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

3.  Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists.

Authors:  Orestis A Panagiotou; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2012-04-25       Impact factor: 6.437

4.  Practical considerations in choosing between the case-cohort and nested case-control designs.

Authors:  S Wacholder
Journal:  Epidemiology       Date:  1991-03       Impact factor: 4.822

Review 5.  Variance estimation for complex surveys using replication techniques.

Authors:  K F Rust; J N Rao
Journal:  Stat Methods Med Res       Date:  1996-09       Impact factor: 3.021

6.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors:  P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

7.  Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.

Authors:  Yin Cao; Sara Lindström; Fredrick Schumacher; Victoria L Stevens; Demetrius Albanes; Sonja Berndt; Heiner Boeing; H Bas Bueno-de-Mesquita; Federico Canzian; Saioa Chamosa; Stephen J Chanock; W Ryan Diver; Susan M Gapstur; J Michael Gaziano; Edward L Giovannucci; Christopher A Haiman; Brian Henderson; Mattias Johansson; Loïc Le Marchand; Domenico Palli; Bernard Rosner; Afshan Siddiq; Meir Stampfer; Daniel O Stram; Rulla Tamimi; Ruth C Travis; Dimitrios Trichopoulos; Walter C Willett; Meredith Yeager; Peter Kraft; Ann W Hsing; Michael Pollak; Xihong Lin; Jing Ma
Journal:  J Natl Cancer Inst       Date:  2014-06       Impact factor: 13.506

  7 in total
  2 in total

1.  Improving External Validity of Epidemiologic Cohort Analyses: A Kernel Weighting Approach.

Authors:  Lingxiao Wang; Barry I Graubard; Hormuzd A Katki; Yan Li
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2020-04-25       Impact factor: 2.483

2.  Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events.

Authors:  Hélène Gouze; Philippe Aegerter; Roula Said-Nahal; Marie Zins; Marcel Goldberg; Guillaume Morelle; Georg Schett; Maxime Breban; Maria Antonietta D'Agostino
Journal:  Arthritis Res Ther       Date:  2022-02-24       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.